Data Montioring Committee
page
1
of
1
Novartis ends study of drug in high risk patients
Dec 20, 2011 02:26 EST
ZURICH, Dec 20 - Swiss drugmaker Novartis said it was ending a study of a drug to treat high blood pressure after an independent body said it could increase risk to patients with a high risk of heart or kidney problems.
page
1
of
1
